The Burden in Caregivers of Multiple Myeloma Patients Undergoing Outpatient Autologous Stem-Cell Transplantation Compared to Inpatient Transplantation

Goldschmidt, 2019, Navigating the treatment landscape in multiple myeloma: which combinations to use and when?, Ann Hematol, 98, 1, 10.1007/s00277-018-3546-8 Ola Landgren, 2020, Multiple myeloma: current advances and future directions, Best Pract Res Clin Haematol, 33, 101155, 10.1016/j.beha.2020.101155 Palumbo, 2014, Autologous transplantation and maintenance therapy in multiple myeloma, N Engl J Med, 371, 895, 10.1056/NEJMoa1402888 Gay, 2015, Chemotherapy plus lenalidomide versus autologous transplantation, followed by lenalidomide plus prednisone versus lenalidomide maintenance, in patients with multiple myeloma: a randomised, multicentre, phase 3 trial, Lancet Oncol, 16, 1617, 10.1016/S1470-2045(15)00389-7 Cavo, 2020, Lancet Haematol, 7, e456, 10.1016/S2352-3026(20)30099-5 Attal, 2017, Lenalidomide, bortezomib, and dexamethasone with transplantation for myeloma, N Engl J Med, 376, 1311, 10.1056/NEJMoa1611750 D’Souza, 2020, Current Use of and Trends in Hematopoietic Cell Transplantation in the United States, Biol Blood Marrow Transplant, 26, e177, 10.1016/j.bbmt.2020.04.013 Passweg, 2020, The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus, Bone Marrow Transplant, 10.1038/s41409-020-0826-4 Morabito, 2002, Feasibility of a mixed inpatient–outpatient model of peripheral blood stem cell transplantation for multiple myeloma, Haematologica, 87, 1192 Gertz, 2008, Autologous stem cell transplant in 716 patients with multiple myeloma: low treatment-related mortality, feasibility of outpatient transplant, and effect of a multidisciplinary quality initiative, Mayo Clin Proc, 83, 1131, 10.4065/83.10.1131 Anastasia, 2009, Early discharge after high-dose melphalan and peripheral blood stem cell reinfusion in patients with hematological and non-hematological disease, Leuk Lymphoma, 50, 80, 10.1080/10428190802535098 Faucher, 2012, Randomized study of early hospital discharge following autologous blood SCT: medical outcomes and hospital costs, Bone Marrow Transplant, 47, 549, 10.1038/bmt.2011.126 Martino, 2014, Very low rate of readmission after an early discharge outpatient model for autografting in multiple myeloma patients: an Italian multicenter retrospective study, Biol Blood Marrow Transplant, 20, 1026, 10.1016/j.bbmt.2014.03.027 Martino, 2015, A home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study, Leuk Lymphoma, 56, 801, 10.3109/10428194.2014.931952 Shah, 2017, Inpatient vs outpatient autologous hematopoietic stem cell transplantation for multiple myeloma, Eur J Haematol, 99, 532, 10.1111/ejh.12970 Lisenko, 2017, High-dose chemotherapy and autologous stem cell transplantation of patients with multiple myeloma in an outpatient setting, BMC Cancer, 17, 151, 10.1186/s12885-017-3137-4 Giralt, 2010, 200 mg/m2 melphalan—the gold standard for multiple myeloma, Nat Rev Clin Oncol, 7, 490, 10.1038/nrclinonc.2010.104 Martino, 2013, Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma, Expert Opin Investig Drugs, 22, 619, 10.1517/13543784.2013.788643 Martino, 2016, Italian consensus conference for the outpatient autologous stem cell transplantation management in multiple myeloma, Bone Marrow Transplant, 51, 1032, 10.1038/bmt.2016.79 Owattanapanich, 2018, Risk of febrile neutropenia among patients with multiple myeloma or lymphoma who undergo inpatient versus outpatient autologous stem cell transplantation: a systematic review and meta-analysis, BMC Cancer, 18, 1126, 10.1186/s12885-018-5054-6 Holbro, 2013, Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma, Biol Blood Marrow Transplant, 19, 547, 10.1016/j.bbmt.2012.12.006 Martino, 2017, Autologous stem cell transplantation in patients with multiple myeloma: an activity-based costing analysis, comparing a total inpatient model versus an early discharge model, Clin Lymphoma Myeloma Leuk, 17, 506, 10.1016/j.clml.2017.05.018 Summers, 2000, A comparison of inpatient and outpatient ASCT, Bone Marrow Transplant, 26, 389, 10.1038/sj.bmt.1702534 Martino, 2018, A comparative assessment of quality of life in patients with multiple myeloma undergoing autologous stem cell transplantation through an outpatient and inpatient model, Biol Blood Marrow Transplant, 24, 608, 10.1016/j.bbmt.2017.09.021 Gemmill, 2011, Informal caregivers of hematopoietic cell transplant patients: a review and recommendations for interventions and research, Cancer Nurs, 34, E13, 10.1097/NCC.0b013e31820a592d Beattie, 2011, The experience of caregivers of hematological cancer patients undergoing a hematopoietic stem cell transplant: a comprehensive literature review, Psychooncology, 20, 1137, 10.1002/pon.1962 Stiff, 2006, Autologous hematopoietic stem cell transplants that utilize total body irradiation can safely be carried out entirely on an outpatient basis, Bone Marrow Transplant, 38, 757, 10.1038/sj.bmt.1705525 Kumar, 2016, International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma, Lancet Oncol, 17, e328, 10.1016/S1470-2045(16)30206-6 Nijboer, 1999, Measuring both negative and positive reactions to giving care to cancer patients: psychometric qualities of the Caregiver Reaction Assessment (CRA), Soc Sci Med, 48, 1259, 10.1016/S0277-9536(98)00426-2 Sorror, 2005, Hematopoietic Cell Transplantation (HCT)-Specific Comorbidity Index: a new tool for risk assessment before allogeneic HCT, Blood, 106, 2912, 10.1182/blood-2005-05-2004 Schulmeister, 2005, Quality of life, quality of care, and patient satisfaction: perceptions of patients undergoing outpatient autologous stem cell transplantation, Oncol Nurs Forum, 32, 57, 10.1188/05.ONF.57-67 Foster, 2013, Validating the positive impact of in-hospital lay care-partner support on patient survival in allogeneic BMT: a prospective study, Bone Marrow Transplant, 48, 671, 10.1038/bmt.2012.208 Grimm, 2000, Caregiver responses and needs. An ambulatory bone marrow transplant model, Cancer Pract, 8, 120, 10.1046/j.1523-5394.2000.83005.x Meisenberg, 1998, Reduced charges and costs associated with outpatient autologous stem cell transplantation, Bone Marrow Transplant, 21, 927, 10.1038/sj.bmt.1701191 Fernández-Avilés, 2006, Case–control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies, J Clin Oncol, 24, 4855, 10.1200/JCO.2006.06.4238 Frey, 2002, Lack of caregivers limits use of outpatient hematopoietic stem cell transplant program, Bone Marrow Transplant, 30, 741, 10.1038/sj.bmt.1703676 El-Jawahri, 2016, Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial, JAMA, 316, 2094, 10.1001/jama.2016.16786 El-Jawahri, 2015, Quality of life and mood of patients and family caregivers during hospitalization for hematopoietic stem cell transplantation, Cancer, 121, 951, 10.1002/cncr.29149 Stephan, 2013, Validity, reliability, and feasibility of the German version of the Caregiver Reaction Assessment scale (G-CRA): a validation study, Int Psychogeriatr, 25, 1621, 10.1017/S1041610213001178 Pennell, 2017, mHealth: mobile technologies to virtually bring the patient into an oncology practice, Am Soc Clin Oncol Educ Book, 37, 144, 10.1200/EDBK_176093 Melton, 2017, Increasing access to care for young adults with cancer: results of a quality-improvement project using a novel telemedicine approach to supportive group psychotherapy, Palliat Support Care, 15, 176, 10.1017/S1478951516000572